Drugs / 7.5 mg GC, PO (in the mouth) on day 1 through 5.
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00619372 | Jan → Apr 2008 | — | Hadassah Medical Organization | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 7.5 mg GC, PO (in the mouth) on day 1 through 5. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00619372 ↗ |
| Route | Oral | “7.5 mg GC, PO (in the mouth) on day 1 through 5.” NCT00619372 ↗ |